| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 0628T707D0 |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hidradenitis Suppurativa | 2 | D017497 | ClinicalTrials |
| Sjogren's Syndrome | 2 | D012859 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
| Graves Disease | 2 | D006111 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Myasthenia Gravis | 2 | D009157 | ClinicalTrials |
| Lupus Nephritis | 2 | D008181 | ClinicalTrials |
| Arthritis, Rheumatoid | 1 | D001172 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298210 |
| FDA SRS | 0628T707D0 |
CONTENTS